ThomasYvanRegenbogenMD

Fellow, Medical Oncology and Hematology

Dr. Regenbogen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
5303 Elliot Dr
Ypsilanti, MI 48197
Phone+1 734-712-1000

Fax+1 734-712-1012

SSM Health/Saint Louis University School of MedicineFellowship, Hematology and Medical Oncology, 2014 - 2017
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2014 - 2017
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2010 - 2013
University College of Dublin National Univ SOMClass of 2010

PubMed

Choosing and managing a career as a community practitioner.
Thomas Regenbogen
Clinical Advances in Hematology & Oncology. 2019-01-01
18 citations
State of the Art: Concise ReviewReview of Ongoing Clinical Trials in Non–Small-Cell Lung Cancer: A Status Report for 2012 from the ClinicalTrials.gov Web Site
Janakiraman Subramanian, Thomas Regenbogen, Gayathri Nagaraj, Alex R. Lane, Siddhartha Devarakonda
Journal of Thoracic Oncology. 2013-07-01
4 citations
Review of ongoing clinical trials in non-small cell lung cancer: a status report for 2009 from the ClinicalTrials.gov website.
Janakiraman Subramanian, Anusha R Madadi, Monica Dandona, Kristina Williams, Daniel Morgensztern
Journal of Thoracic Oncology. 2010-08-01

Books/Book Chapters

The Washington Manual of Outpatient Internal Medicine
Chapter: Hematology
Regenbogen T, Blinder M.Editors: Sateia H, DeFer T.Lippincott Williams and Wilkins, PhiladelphiaEdition 2,2015
The Washington Manual of Medical Therapeutics
Chapter: Hematology
Blinder M, Regenbogen T, Zhou A.Editors: Ramgopal R, et al..Lippincott Williams and Wilkins, PhiladelphiaEdition 35,2015